Metoprolol Succinate Extended Release Tablets IP 50MG – Preslol 50 ER Tablets

PRESLOL 50 ER Tablets
Composition:- Metoprolol 50 mg Extended Release

PRESLOL 50 ER Tablets – Metoprolol Succinate Extended Release Tablets IP 50MG delivers Metoprolol Succinate 50 mg in an Extended Release (ER) formulation. As a cardioselective β1-blocker, it lowers heart rate, cardiac output, and blood pressure by selectively blocking β1-adrenergic receptors in the heart. The ER technology allows for controlled and steady drug release, ensuring round-the-clock efficacy with once-daily dosing. It is a trusted choice in the management of moderate-to-severe hypertension, angina, arrhythmias, and for long-term cardiac protection following myocardial infarction.

Key Points of Metoprolol Succinate Extended Release Tablets – PRESLOL 50 ER Tablets
• Sustained Release Profile – Provides effective 24-hour control with convenient once-daily administration.
• Heart-Specific Action – Cardioselective effect reduces strain on the heart with minimal impact on lungs and blood vessels.
• Consistent BP Control – Maintains reliable reduction of both systolic and diastolic blood pressure in moderate hypertension.
• Anti-Anginal & Anti-Arrhythmic Benefit – Decreases cardiac workload, stabilizes rhythm, and reduces angina frequency.
• Cardioprotective in Post-MI Patients – Enhances recovery and lowers risk of further cardiac events.

Can be Prescribed by:
• Cardiologists
• General Physicians
• Healthcare practitioner

Disclaimer: To be used under medical supervision only. Not intended for general public promotion. This content is meant for registered healthcare professionals only.